Skip to main content
Book cover

Melatonin, Neuroprotective Agents and Antidepressant Therapy

  • Book
  • © 2016

Overview

  • Detailed information on etiology of mood disorders

  • Provides recent thoughts on melatonin, its receptors and their role in circadian rhythms, and sleep and mood disorders

  • Describes therapeutic actions of antidepressants

  • Includes melatonergic agonists, their use in insomnia, psychiatric and neurological disorders

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (51 chapters)

Keywords

About this book

This work is a guidebook for clinicians who are involved in treating depressive patients and also serves the research scientists who are working on the psychopharmacological mechanisms of antidepressant actions and psychopathological mechanisms underlying mood disorders. Mood disorders such as major depressive disorder (MDD), bipolar disorder (BPD) and seasonal affective disorder (SAD) are the most disabling disorders that are among the most expensive of all medical illnesses. The pathophysiology of mood disorders is very complex and involves many mechanisms like circadian rhythm disruption, sleep abnormalities, melatonin rhythm abnormalities and alterations in melatonin receptor mechanisms, abnormalities   in monoaminergic neurotransmitter mechanisms, glutamatergic release mechanisms, hippocampal neurogenesis, and abnormal immune and cytokine release mechanisms. Many antidepressants that are in clinical use today including the recently introduced novel agents like agomelatine or other antidepressants cause clinical remission by resynchronizing disrupted circadian rhythms and melatonin receptor functions, enhancing monoaminergic neurotransmission, promoting hippocampal neurogenesis, and regulating immune mechanisms. This book explains various etiological factors that are involved in the pathogenesis of mood disorders and the mechanisms of therapeutic actions of antidepressants including the recently introduced agomelatine and other antidepressants that exhibit rapid onset of action with greater efficacy and fewer side effects. .

Editors and Affiliations

  • Vice-Rectorate for Research and Sci, Camilo José Cela University Vice-Rectorate for Research and Sci, Madrid, Spain

    Francisco López-Muñoz

  • International Medical Sciences Research Study Center, Sri Sathya Sai Medical Educational & Research Foundation, Coimbatore, India

    Venkataramanujam Srinivasan

  • Department of Neurosciences and Ima, University of Chieti Department of Neurosciences and Ima, Italy, Italy

    Domenico de Berardis

  • Department of Biomedical Sciences (Pharmacology Area), University of Alcalá, Madrid, Spain

    Cecilio Álamo

  • Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan

    Takahiro A. Kato

About the editors

Prof.Venkataramanujan Srinivasan,Msc, Ph.D MAMS SRI SATHYA SAI MEDICAL EDUCATIONAL AND RESEARCH FOUNDATION An International Medical Sciences Research Study Center “PrasanthiNilayam”, KOVAI, Coimbatore, Tamilnadu, INDIA

Bibliographic Information

  • Book Title: Melatonin, Neuroprotective Agents and Antidepressant Therapy

  • Editors: Francisco López-Muñoz, Venkataramanujam Srinivasan, Domenico de Berardis, Cecilio Álamo, Takahiro A. Kato

  • DOI: https://doi.org/10.1007/978-81-322-2803-5

  • Publisher: Springer New Delhi

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer India 2016

  • Hardcover ISBN: 978-81-322-2801-1Published: 01 December 2016

  • Softcover ISBN: 978-81-322-3842-3Published: 20 July 2018

  • eBook ISBN: 978-81-322-2803-5Published: 16 November 2016

  • Edition Number: 1

  • Number of Pages: XXV, 921

  • Number of Illustrations: 65 b/w illustrations, 113 illustrations in colour

  • Topics: Neurology, Psychopharmacology, Internal Medicine

Publish with us